Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 03-1998 | 12-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,600 | 7,150 | 8,600 | 5,140 | 4,106 |
| Other current assets | 90 | 990 | 450 | 230 | 246 |
| TOTAL | $6,690 | $8,140 | $9,050 | $5,370 | $4,352 |
| Non-Current Assets | |||||
| PPE Net | 500 | 430 | 390 | N/A | 191 |
| Other Non-Current Assets | 10 | 20 | 40 | 10 | 0 |
| TOTAL | $510 | $450 | $430 | $10 | $191 |
| Total Assets | $6,950 | $8,360 | $9,260 | $5,580 | $4,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 480 | 260 | 320 | 260 | 0 |
| Other current liabilities | 0 | 0 | 0 | 500 | N/A |
| TOTAL | $480 | $260 | $320 | $760 | $627 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $60 | $N/A |
| Total Liabilities | $480 | $260 | $320 | $830 | $627 |
| Shareholders' Equity | |||||
| Common Shares | 27,130 | 26,510 | 26,360 | 18,530 | 18,558 |
| Retained earnings | -20,760 | -18,500 | -17,510 | -13,870 | N/A |
| Other shareholders' equity | 0 | -10 | 0 | 0 | -14,543 |
| TOTAL | $6,460 | $8,090 | $8,940 | $4,750 | $4,015 |
| Total Liabilities And Equity | $6,940 | $8,350 | $9,260 | $5,580 | $4,642 |